Natures Sunshine Products Inc (NATR) stock
NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3058% below fair value
$10.33−0.23 (-2.18%)
Close on Nov 17, 2026Market cap $181.76MP/E 10.2Yield –
Natures Sunshine Products cash
Cash and short-term investments held at the end of each period.
Natures Sunshine Products's cash was $82.50M at Jun 30, 2026. For fiscal 2025 it was $93.89M, up 10.9% from the year before. Over ten years it grew 8.5% a year on average. The highest annual figure on record is $93.89M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $93.89M | +10.9% |
| FY2024 | Dec 31, 2024 | $84.70M | +2.8% |
| FY2023 | Dec 31, 2023 | $82.37M | +37.2% |
| FY2022 | Dec 31, 2022 | $60.03M | -30.3% |
| FY2021 | Dec 31, 2021 | $86.18M | -6.4% |
| FY2020 | Dec 31, 2020 | $92.07M | +71.7% |
| FY2019 | Dec 31, 2019 | $53.63M | +5.9% |
| FY2018 | Dec 31, 2018 | $50.64M | +18.0% |
| FY2017 | Dec 31, 2017 | $42.91M | +32.9% |
| FY2016 | Dec 31, 2016 | $32.28M | -22.1% |
| FY2015 | Dec 31, 2015 | $41.42M | -29.4% |
| FY2014 | Dec 31, 2014 | $58.70M | -24.0% |
| FY2013 | Dec 31, 2013 | $77.25M | -2.5% |
| FY2012 | Dec 31, 2012 | $79.24M | +34.4% |
| FY2011 | Dec 31, 2011 | $58.97M | +23.9% |
| FY2010 | Dec 31, 2010 | $47.60M | +34.0% |
| FY2009 | Dec 31, 2009 | $35.54M | +2.0% |
| FY2008 | Dec 31, 2008 | $34.85M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $82.50M | +1.4% |
| Q1 FY2026 | Mar 31, 2026 | $87.58M | +1.3% |
| Q4 FY2025 | Dec 31, 2025 | $93.89M | +10.9% |
| Q3 FY2025 | Sep 30, 2025 | $95.55M | +21.4% |
| Q2 FY2025 | Jun 30, 2025 | $81.35M | +18.4% |
| Q1 FY2025 | Mar 31, 2025 | $86.49M | +11.2% |
| Q4 FY2024 | Dec 31, 2024 | $84.70M | +2.8% |
| Q3 FY2024 | Sep 30, 2024 | $78.70M | +3.5% |
| Q2 FY2024 | Jun 30, 2024 | $68.70M | -0.4% |
| Q1 FY2024 | Mar 31, 2024 | $77.77M | +18.3% |
| Q4 FY2023 | Dec 31, 2023 | $82.37M | +37.2% |
| Q3 FY2023 | Sep 30, 2023 | $76.04M | +33.4% |
| Q2 FY2023 | Jun 30, 2023 | $68.97M | +22.4% |
| Q1 FY2023 | Mar 31, 2023 | $65.72M | -1.2% |
| Q4 FY2022 | Dec 31, 2022 | $60.03M | -30.3% |
| Q3 FY2022 | Sep 30, 2022 | $56.98M | -24.6% |
| Q2 FY2022 | Jun 30, 2022 | $56.34M | -24.8% |
| Q1 FY2022 | Mar 31, 2022 | $66.54M | -27.1% |
| Q4 FY2021 | Dec 31, 2021 | $86.18M | -6.4% |
| Q3 FY2021 | Sep 30, 2021 | $75.54M | -8.2% |
| Q2 FY2021 | Jun 30, 2021 | $74.90M | +6.6% |
| Q1 FY2021 | Mar 31, 2021 | $91.25M | +42.3% |
| Q4 FY2020 | Dec 31, 2020 | $92.07M | +71.7% |
| Q3 FY2020 | Sep 30, 2020 | $82.26M | +62.8% |
| Q2 FY2020 | Jun 30, 2020 | $70.26M | +51.6% |
| Q1 FY2020 | Mar 31, 2020 | $64.15M | +39.1% |
| Q4 FY2019 | Dec 31, 2019 | $53.63M | +5.9% |
| Q3 FY2019 | Sep 30, 2019 | $50.53M | +5.6% |
| Q2 FY2019 | Jun 30, 2019 | $46.34M | -1.2% |
| Q1 FY2019 | Mar 31, 2019 | $46.12M | +9.0% |
| Q4 FY2018 | Dec 31, 2018 | $50.64M | +18.0% |
| Q3 FY2018 | Sep 30, 2018 | $47.86M | +0.4% |
| Q2 FY2018 | Jun 30, 2018 | $46.90M | +47.4% |
| Q1 FY2018 | Mar 31, 2018 | $42.30M | +28.0% |
| Q4 FY2017 | Dec 31, 2017 | $42.91M | +32.9% |
| Q3 FY2017 | Sep 30, 2017 | $47.69M | +17.9% |
| Q2 FY2017 | Jun 30, 2017 | $31.82M | – |
| Q1 FY2017 | Mar 31, 2017 | $33.06M | – |
| Q4 FY2016 | Dec 31, 2016 | $32.28M | – |
| Q3 FY2016 | Sep 30, 2016 | $40.44M | – |
See a number that looks wrong?